Annual Cash & Cash Equivalents
$20.75 M
-$23.83 M-53.45%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual cash & cash equivalents is $20.75 million, with the most recent change of -$23.83 million (-53.45%) on December 31, 2023.
- During the last 3 years, QNCX annual cash & cash equivalents has fallen by -$46.09 million (-68.95%).
- QNCX annual cash & cash equivalents is now -70.24% below its all-time high of $69.72 million, reached on December 31, 2021.
Performance
QNCX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.67 M
-$5.21 M-66.10%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly cash and cash equivalents is $2.67 million, with the most recent change of -$5.21 million (-66.10%) on September 30, 2024.
- Over the past year, QNCX quarterly cash and cash equivalents has dropped by -$18.08 million (-87.11%).
- QNCX quarterly cash and cash equivalents is now -96.88% below its all-time high of $85.61 million, reached on March 31, 2020.
Performance
QNCX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
QNCX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.5% | -87.1% |
| 3 y3 years | -69.0% | -87.1% |
| 5 y5 years | -16.6% | -87.1% |
QNCX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.2% | at low | -96.2% | at low |
| 5 y | 5-year | -70.2% | at low | -96.9% | at low |
| alltime | all time | -70.2% | +182.6% | -96.9% | at low |
Quince Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.67 M(-66.1%) |
| Jun 2024 | - | $7.89 M(-63.8%) |
| Mar 2024 | - | $21.81 M(+5.1%) |
| Dec 2023 | $20.75 M(-53.4%) | $20.75 M(-4.1%) |
| Sep 2023 | - | $21.63 M(-4.5%) |
| Jun 2023 | - | $22.65 M(-51.5%) |
| Mar 2023 | - | $46.71 M(+4.8%) |
| Dec 2022 | $44.58 M(-36.1%) | $44.58 M(+40.1%) |
| Sep 2022 | - | $31.81 M(-32.2%) |
| Jun 2022 | - | $46.93 M(-30.5%) |
| Mar 2022 | - | $67.56 M(-3.1%) |
| Dec 2021 | $69.72 M | $69.72 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $62.21 M(-16.0%) |
| Jun 2021 | - | $74.05 M(-13.2%) |
| Mar 2021 | - | $85.31 M(+27.6%) |
| Dec 2020 | $66.84 M(+30.5%) | $66.84 M(+4.0%) |
| Sep 2020 | - | $64.25 M(-2.9%) |
| Jun 2020 | - | $66.16 M(-22.7%) |
| Mar 2020 | - | $85.61 M(+67.2%) |
| Dec 2019 | $51.21 M(+105.9%) | $51.21 M(+14.5%) |
| Sep 2019 | - | $44.74 M(+1.0%) |
| Jun 2019 | - | $44.31 M(+114.8%) |
| Mar 2019 | - | $20.63 M(-17.0%) |
| Dec 2018 | $24.87 M(+238.7%) | $24.87 M |
| Dec 2017 | $7.34 M | - |
FAQ
- What is Quince Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Quince Therapeutics?
- What is Quince Therapeutics annual cash & cash equivalents year-on-year change?
- What is Quince Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Quince Therapeutics?
- What is Quince Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Quince Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of QNCX is $20.75 M
What is the all time high annual cash & cash equivalents for Quince Therapeutics?
Quince Therapeutics all-time high annual cash & cash equivalents is $69.72 M
What is Quince Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, QNCX annual cash & cash equivalents has changed by -$23.83 M (-53.45%)
What is Quince Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of QNCX is $2.67 M
What is the all time high quarterly cash and cash equivalents for Quince Therapeutics?
Quince Therapeutics all-time high quarterly cash and cash equivalents is $85.61 M
What is Quince Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, QNCX quarterly cash and cash equivalents has changed by -$18.08 M (-87.11%)